Literature DB >> 17469335

[Cardiac remodeling and inflammation].

Martín Martínez Rosas1.   

Abstract

The cardiac remodeling is a progressive response of the heart to acute and chronic insults regardless its etiology. This process is characterized by changes in the size, shape and function and is associated with a worse prognosis in patients with heart failure. The acute myocardial infarction is the most common cause of remodeling. In the first minutes after injury in the ischemic zone there is an important augment in the synthesis and release of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6), interleukin-1-beta (IL-1beta) and transforming growth factor 1-beta (TGF-1beta). This acute releasing of cytokines could regulate the survival or apoptosis of myocytes in infarcted zone and, their negative inotropic effects could represent an adaptative response to delimit the injury and to decrease myocardial energy demand. This significant upregulation of proinflammatory cytokines can extend to noninfarcted zone and triggers a second phase of elevated levels of cytokines that promote interstitial fibrosis and collagen deposition in the contralateral noninfarcted myocardium leading to a dysfunctional ventricle. This article will review the recent reports that support the idea of a cardioprotective role for this early inflammatory response and a deleterious role of the delayed response that mediate the fibrosis that is a typical feature of the remodeling process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17469335

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  6 in total

1.  Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Li Liu; Robert A Ahokas; Yao Sun
Journal:  Int J Cardiol       Date:  2012-07-19       Impact factor: 4.164

2.  Platelet-derived growth factor blockade on cardiac remodeling following infarction.

Authors:  Chang Liu; Wenyuan Zhao; Weixin Meng; Tieqiang Zhao; Yuanjian Chen; Robert A Ahokas; Hongyu Liu; Yao Sun
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

3.  Platelet-derived growth factor involvement in myocardial remodeling following infarction.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Valerie Huang; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  J Mol Cell Cardiol       Date:  2011-07-13       Impact factor: 5.000

4.  p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.

Authors:  Huiqiu Yin; Jidong Zhang; Haiqing Lin; Rong Wang; Yun Qiao; Bo Wang; Fenye Liu
Journal:  Inflammation       Date:  2007-10-18       Impact factor: 4.092

5.  Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis.

Authors:  Bin Fan; Likun Ma; Qian Li; Lin Wang; Junling Zhou; Jiawei Wu
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

6.  H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose.

Authors:  Xiaohui Zhang; Yu Fu; Hui Li; Li Shen; Qing Chang; Liya Pan; Siting Hong; Xinhua Yin
Journal:  J Cell Mol Med       Date:  2018-01-05       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.